secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indivior Pharmaceuticals, Inc. (INDV)
CIK:        0001625297
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001625297-25-000072
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indivior shareholders approve scheme of arrangement to restructure, court hearing Jan 22, 2026
--------------------------------------------------------------------------------

- Amended articles effective Dec 11 to facilitate scheme ensuring all shareholders become holders of Indivior Pharmaceuticals shares.
- Court meeting: 94,968,161 votes for (99.9%) vs 46,544 against; passed by required majorities.
- Extraordinary General Meeting: all 6 special resolutions passed with over 79 million votes for each.
- Completion subject to High Court sanction hearing expected January 22, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625297/000162529725000072/0001625297-25-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625297/000162529725000072/indv-20251211.htm
  HTML page:      https://secwatch.observer/filing/0001625297-25-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer